ClinicalTrials.Veeva

Menu

Investigating Multimodally Endothelial Dysfunction in Ocular and Systemic Disease

U

Universitaire Ziekenhuizen KU Leuven

Status

Enrolling

Conditions

Diastolic Heart Failure
Kidney Diseases
Glaucoma
Small Vessel Disease

Treatments

Diagnostic Test: SphygmoCor
Diagnostic Test: Hyperspectral retinal images
Diagnostic Test: Fundus pictures
Diagnostic Test: Neuropsychological examination
Diagnostic Test: Skin biopsy
Diagnostic Test: Optical coherence tomography(-angiography) OCT(A)
Diagnostic Test: Blood sample
Diagnostic Test: DVA 3.0
Diagnostic Test: Sphygmomanometer

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To explore the distribution of retinal vasculature parameters in patients with different subtypes of cardiovascular and ocular disease.

Full description

In this interventional cohort study, the investigators aim to evaluate retinal vascular function as assessed by optical coherence tomography angiography, fundus photography and dynamic vessel analysis in patients who share microvascular involvement of their pathology (e.g. chronic kidney disease, cardiac decompensation, neuronal small vessel disease and glaucoma) and age-matched healthy controls. Plasm and skin samples for comparative proteomics and transcriptomics are also taken.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult patients with a confirmed or suspect diagnosis of glaucoma based on intra-ocular eye pressure, visual field defect and structural optic nerve changes, regardless their age.
  • Adult patients with chronic kidney disease regardless their age.
  • Adult patients with heart failure with preserved ejection fraction (HFpEF), regardless their age: symptomatic heart failure with Left Ventricle Ejection Fraction > 50% AND BNP > 35 pg/ml (or NT-proBNP>125 pg/ml) OR signs of diastolic dysfunction according to the European Society of Cardiology guidelines 2016
  • Adult patients with confirmed small vessel disease as is diagnosed on routine neurological imaging, regardless their age.
  • People without history or track record of any relevant pathology, including cardiovascular and renal diseases, regardless their age
  • Capable and willing to participate (informed consent)

Exclusion criteria

  • Diabetes
  • Personal medical history of retinal neovascularization.
  • Unable or unwilling to give consent

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

1,000 participants in 5 patient groups

Chronic kidney disease
Other group
Treatment:
Diagnostic Test: Sphygmomanometer
Diagnostic Test: DVA 3.0
Diagnostic Test: Blood sample
Diagnostic Test: Skin biopsy
Diagnostic Test: Optical coherence tomography(-angiography) OCT(A)
Diagnostic Test: Neuropsychological examination
Diagnostic Test: Fundus pictures
Diagnostic Test: Hyperspectral retinal images
Diagnostic Test: SphygmoCor
Diastolic heart failure
Other group
Treatment:
Diagnostic Test: Sphygmomanometer
Diagnostic Test: DVA 3.0
Diagnostic Test: Blood sample
Diagnostic Test: Skin biopsy
Diagnostic Test: Optical coherence tomography(-angiography) OCT(A)
Diagnostic Test: Neuropsychological examination
Diagnostic Test: Fundus pictures
Diagnostic Test: Hyperspectral retinal images
Diagnostic Test: SphygmoCor
Neuronal small vessel disease
Other group
Treatment:
Diagnostic Test: Sphygmomanometer
Diagnostic Test: DVA 3.0
Diagnostic Test: Blood sample
Diagnostic Test: Skin biopsy
Diagnostic Test: Optical coherence tomography(-angiography) OCT(A)
Diagnostic Test: Neuropsychological examination
Diagnostic Test: Fundus pictures
Diagnostic Test: Hyperspectral retinal images
Diagnostic Test: SphygmoCor
Glaucoma
Other group
Treatment:
Diagnostic Test: Sphygmomanometer
Diagnostic Test: DVA 3.0
Diagnostic Test: Blood sample
Diagnostic Test: Skin biopsy
Diagnostic Test: Optical coherence tomography(-angiography) OCT(A)
Diagnostic Test: Neuropsychological examination
Diagnostic Test: Fundus pictures
Diagnostic Test: Hyperspectral retinal images
Diagnostic Test: SphygmoCor
Healthy patients
Other group
Treatment:
Diagnostic Test: Sphygmomanometer
Diagnostic Test: DVA 3.0
Diagnostic Test: Blood sample
Diagnostic Test: Skin biopsy
Diagnostic Test: Optical coherence tomography(-angiography) OCT(A)
Diagnostic Test: Neuropsychological examination
Diagnostic Test: Fundus pictures
Diagnostic Test: Hyperspectral retinal images
Diagnostic Test: SphygmoCor

Trial contacts and locations

1

Loading...

Central trial contact

Sarah Spileers, SC; Jan Van Eijgen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems